About Ahlcon Parenterals
Ahlcon Parenterals is a company based in Delhi (India) founded in 1992 was acquired by B Braun in March 2012. The company has 476 employees as of April 01, 2024.
- Headquarter Delhi, India
- Employees 476 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ahlcon Parenterals (India) Limited
- Date of Incorporation 20 Jan, 1992
- Jurisdiction New Delhi, Delhi, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ahlcon Parenterals
Detailed funding history for Ahlcon Parenterals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Ahlcon Parenterals
Ahlcon Parenterals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Braun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B. Braun is recognized as a leading medical technology company.
|
Locked | Locked | Locked |
Investor details for Ahlcon Parenterals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ahlcon Parenterals
Investment portfolio details for Ahlcon Parenterals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ahlcon Parenterals
Detailed financials for Ahlcon Parenterals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ahlcon Parenterals Comparisons
Peer comparison for Ahlcon Parenterals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ahlcon Parenterals
Detailed competitors of Ahlcon Parenterals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ahlcon Parenterals
Complete news archive for Ahlcon Parenterals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ahlcon Parenterals
Ahlcon Parenterals was founded in 1992.
Ahlcon Parenterals is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Indranil Mukherjee is the current CEO of Ahlcon Parenterals.
As of Apr 01, 2024, the latest employee count at Ahlcon Parenterals is 476.
Annual revenue of Ahlcon Parenterals is $17.98M as on Mar 31, 2021.
Ahlcon Parenterals was founded in 1992 in Delhi, India, within the pharmaceutical sector. Large and small volume parenteral formulations are produced for domestic and export markets. Operations follow Current Good Manufacturing Practices using advanced processes. Products such as infusion therapy solutions, inhalation nebules, topical drops, and injectables are provided. Compliance with global ISO standards is ensured, alongside sustainable manufacturing approaches.
Ahlcon Parenterals has 1 investor. Key investors include B. Braun.